Literature DB >> 21552259

Alternative splicing of SYK regulates mitosis and cell survival.

Panagiotis Prinos1, Daniel Garneau, Jean-François Lucier, Daniel Gendron, Sonia Couture, Marianne Boivin, Jean-Philippe Brosseau, Elvy Lapointe, Philippe Thibault, Mathieu Durand, Karine Tremblay, Julien Gervais-Bird, Hanad Nwilati, Roscoe Klinck, Benoit Chabot, Jean-Pierre Perreault, Raymund J Wellinger, Sherif Abou Elela.   

Abstract

Most human genes produce multiple mRNA isoforms through alternative splicing. However, the biological relevance of most splice variants remains unclear. In this study, we evaluated the functional impact of alternative splicing in cancer cells. We modulated the splicing pattern of 41 cancer-associated splicing events and scored the effects on cell growth, viability and apoptosis, identifying three isoforms essential for cell survival. Specifically, changing the splicing pattern of the spleen tyrosine kinase gene (SYK) impaired cell-cycle progression and anchorage-independent growth. Notably, exposure of cancer cells to epithelial growth factor modulated the SYK splicing pattern to promote the pro-survival isoform that is associated with cancer tissues in vivo. The data suggest that splicing of selected genes is specifically modified during tumor development to allow the expression of isoforms that promote cancer cell survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21552259     DOI: 10.1038/nsmb.2040

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  50 in total

1.  MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain.

Authors:  J Bae; C P Leo; S Y Hsu; A J Hsueh
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

Review 2.  Cell signalling and the control of pre-mRNA splicing.

Authors:  Chanseok Shin; James L Manley
Journal:  Nat Rev Mol Cell Biol       Date:  2004-09       Impact factor: 94.444

3.  Multiple and specific mRNA processing targets for the major human hnRNP proteins.

Authors:  Julian P Venables; Chu-Shin Koh; Ulrike Froehlich; Elvy Lapointe; Sonia Couture; Lyna Inkel; Anne Bramard; Eric R Paquet; Valérie Watier; Mathieu Durand; Jean-François Lucier; Julien Gervais-Bird; Karine Tremblay; Panagiotis Prinos; Roscoe Klinck; Sherif Abou Elela; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

4.  The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.

Authors:  P J Coopman; M T Do; M Barth; E T Bowden; A J Hayes; E Basyuk; J K Blancato; P R Vezza; S W McLeskey; P H Mangeat; S C Mueller
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

5.  Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death.

Authors:  C D Bingle; R W Craig; B M Swales; V Singleton; P Zhou; M K Whyte
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

6.  Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas.

Authors:  A L Feldman; D X Sun; M E Law; A J Novak; A D Attygalle; E C Thorland; S R Fink; J A Vrana; B L Caron; W G Morice; E D Remstein; K L Grogg; P J Kurtin; W R Macon; A Dogan
Journal:  Leukemia       Date:  2008-04-10       Impact factor: 11.528

7.  Identification of alternative splicing markers for breast cancer.

Authors:  Julian P Venables; Roscoe Klinck; Anne Bramard; Lyna Inkel; Geneviève Dufresne-Martin; ChuShin Koh; Julien Gervais-Bird; Elvy Lapointe; Ulrike Froehlich; Mathieu Durand; Daniel Gendron; Jean-Philippe Brosseau; Philippe Thibault; Jean-Francois Lucier; Karine Tremblay; Panagiotis Prinos; Raymund J Wellinger; Benoit Chabot; Claudine Rancourt; Sherif Abou Elela
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

8.  Reprogramming alternative pre-messenger RNA splicing through the use of protein-binding antisense oligonucleotides.

Authors:  Jonathan Villemaire; Isabelle Dion; Sherif Abou Elela; Benoit Chabot
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

9.  Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells.

Authors:  Barbara Nicke; Julie Bastien; Sophia J Khanna; Patricia H Warne; Victoria Cowling; Simon J Cook; Gordon Peters; Oona Delpuech; Almut Schulze; Katrien Berns; Jasper Mullenders; Roderick L Beijersbergen; René Bernards; Trivadi S Ganesan; Julian Downward; David C Hancock
Journal:  Mol Cell       Date:  2005-12-09       Impact factor: 17.970

10.  Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines.

Authors:  John C Castle; Chaolin Zhang; Jyoti K Shah; Amit V Kulkarni; Auinash Kalsotra; Thomas A Cooper; Jason M Johnson
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

View more
  44 in total

1.  Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulators.

Authors:  Laetitia Michelle; Alexandre Cloutier; Johanne Toutant; Lulzim Shkreta; Philippe Thibault; Mathieu Durand; Daniel Garneau; Daniel Gendron; Elvy Lapointe; Sonia Couture; Hervé Le Hir; Roscoe Klinck; Sherif Abou Elela; Panagiotis Prinos; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2011-12-27       Impact factor: 4.272

2.  SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.

Authors:  Gerald Moncayo; Michal Grzmil; Tatiana Smirnova; Pawel Zmarz; Roland M Huber; Debby Hynx; Hubertus Kohler; Yuhua Wang; Hans-Rudolf Hotz; Nancy E Hynes; Georg Keller; Stephan Frank; Adrian Merlo; Brian A Hemmings
Journal:  Neuro Oncol       Date:  2018-04-09       Impact factor: 12.300

3.  Differential expression and alternative splicing of cell cycle genes in imatinib-treated K562 cells.

Authors:  Jing Liu; Jin Lin; Lin-Feng Huang; Bo Huang; Yan-Mei Xu; Jing Li; Yan Wang; Jing Zhang; Wei-Ming Yang; Qing-Hua Min; Xiao-Zhong Wang
Journal:  Tumour Biol       Date:  2015-05-17

4.  Syk interacts with and phosphorylates nucleolin to stabilize Bcl-x(L) mRNA and promote cell survival.

Authors:  Wen-Horng Wang; Michael O Childress; Robert L Geahlen
Journal:  Mol Cell Biol       Date:  2014-08-04       Impact factor: 4.272

5.  Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression.

Authors:  Roberto Ferrarese; Griffith R Harsh; Ajay K Yadav; Eva Bug; Daniel Maticzka; Wilfried Reichardt; Stephen M Dombrowski; Tyler E Miller; Anie P Masilamani; Fangping Dai; Hyunsoo Kim; Michael Hadler; Denise M Scholtens; Irene L Y Yu; Jürgen Beck; Vinodh Srinivasasainagendra; Fabrizio Costa; Nicoleta Baxan; Dietmar Pfeifer; Dominik von Elverfeldt; Rolf Backofen; Astrid Weyerbrock; Christine W Duarte; Xiaolin He; Marco Prinz; James P Chandler; Hannes Vogel; Arnab Chakravarti; Jeremy N Rich; Maria S Carro; Markus Bredel
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

6.  RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues.

Authors:  Julian P Venables; Jean-Philippe Brosseau; Gilles Gadea; Roscoe Klinck; Panagiotis Prinos; Jean-François Beaulieu; Elvy Lapointe; Mathieu Durand; Philippe Thibault; Karine Tremblay; François Rousset; Jamal Tazi; Sherif Abou Elela; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2012-11-12       Impact factor: 4.272

7.  Identification of novel splice variants and exons of human endothelial cell-specific chemotaxic regulator (ECSCR) by bioinformatics analysis.

Authors:  Jia Lu; Chaokun Li; Chunwei Shi; James Balducci; Hanju Huang; Hong-Long Ji; Yongchang Chang; Yao Huang
Journal:  Comput Biol Chem       Date:  2012-10-23       Impact factor: 2.877

8.  Syk Is Recruited to Stress Granules and Promotes Their Clearance through Autophagy.

Authors:  Mariya O Krisenko; Reneé L Higgins; Soumitra Ghosh; Qing Zhou; Joy S Trybula; Wen-Horng Wang; Robert L Geahlen
Journal:  J Biol Chem       Date:  2015-10-01       Impact factor: 5.157

Review 9.  Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.

Authors:  Mariya O Krisenko; Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2014-11-04

10.  Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia.

Authors:  Thirunavukkarasu Velusamy; Nallasivam Palanisamy; Shanker Kalyana-Sundaram; Anagh Anant Sahasrabuddhe; Christopher A Maher; Daniel R Robinson; David W Bahler; Timothy T Cornell; Thomas E Wilson; Megan S Lim; Arul M Chinnaiyan; Kojo S J Elenitoba-Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.